Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19. Reply
N Engl J Med
.
2021 Sep 16;385(12):1147-1149.
doi: 10.1056/NEJMc2108482.
Epub 2021 Aug 18.
Authors
Anthony C Gordon
1
,
Derek C Angus
2
,
Lennie P G Derde
3
Affiliations
1
Imperial College London, London, United Kingdom anthony.gordon@imperial.ac.uk.
2
University of Pittsburgh, Pittsburgh, PA.
3
University Medical Center Utrecht, Utrecht, the Netherlands.
PMID:
34407335
DOI:
10.1056/NEJMc2108482
No abstract available
Publication types
Letter
Comment
MeSH terms
COVID-19*
Critical Illness*
Humans
Receptors, Interleukin-6
SARS-CoV-2
Substances
Receptors, Interleukin-6